Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 367

1.

Early aggressive intraocular pressure lowering, target intraocular pressure, and a novel concept for glaucoma care.

Singh K, Shrivastava A.

Surv Ophthalmol. 2008 Nov;53 Suppl1:S33-8. doi: 10.1016/j.survophthal.2008.08.007. Review.

PMID:
19038622
2.

Predictors of long-term progression in the early manifest glaucoma trial.

Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z; EMGT Group.

Ophthalmology. 2007 Nov;114(11):1965-72. Epub 2007 Jul 12.

PMID:
17628686
3.

Emerging perspectives in glaucoma: optimizing 24-hour control of intraocular pressure.

Wax MB, Camras CB, Fiscella RG, Girkin C, Singh K, Weinreb RN.

Am J Ophthalmol. 2002 Jun;133 Suppl:S1-10. Review.

PMID:
12034167
4.

Factors that predict the benefit of lowering intraocular pressure in normal tension glaucoma.

Anderson DR, Drance SM, Schulzer M; Collaborative Normal-Tension Glaucoma Study Group.

Am J Ophthalmol. 2003 Nov;136(5):820-9.

PMID:
14597032
5.

Canadian perspectives in glaucoma management: setting target intraocular pressure range.

Damji KF, Behki R, Wang L; Target IOP Workshop participants.

Can J Ophthalmol. 2003 Apr;38(3):189-97. Review.

PMID:
12733686
6.

How does lowering of intraocular pressure protect the optic nerve?

Mackenzie P, Cioffi G.

Surv Ophthalmol. 2008 Nov;53 Suppl1:S39-43. doi: 10.1016/j.survophthal.2008.08.008. Review.

PMID:
19038623
7.

Long-term relationship between intraocular pressure and visual field loss in primary open-angle glaucoma.

Inatani M, Iwao K, Inoue T, Awai M, Muto T, Koga T, Ogata-Iwao M, Hara R, Futa R, Tanihara H.

J Glaucoma. 2008 Jun-Jul;17(4):275-9. doi: 10.1097/IJG.0b013e31815c3ab7.

PMID:
18552612
8.

The Finnish evidence-based guideline for open-angle glaucoma.

Tuulonen A, Airaksinen PJ, Erola E, Forsman E, Friberg K, Kaila M, Klemetti A, Mäkelä M, Oskala P, Puska P, Suoranta L, Teir H, Uusitalo H, Vainio-Jylhä E, Vuori ML.

Acta Ophthalmol Scand. 2003 Feb;81(1):3-18.

9.

Treatment of glaucoma patients with insufficient intraocular pressure control: a survey of German ophthalmologists in private practice.

Vorwerk C, Thelen U, Buchholz P, Kimmich F.

Curr Med Res Opin. 2008 May;24(5):1295-301. doi: 10.1185/030079908X291976 . Epub 2008 Mar 25.

PMID:
18366862
10.

Currents on target intraocular pressure and intraocular pressure fluctuations in glaucoma management.

Detry-Morel M.

Bull Soc Belge Ophtalmol. 2008;(308):35-43. Review.

PMID:
18700453
11.

Corneal thickness measurement in the management of primary open-angle glaucoma: a report by the American Academy of Ophthalmology.

Dueker DK, Singh K, Lin SC, Fechtner RD, Minckler DS, Samples JR, Schuman JS.

Ophthalmology. 2007 Sep;114(9):1779-87.

PMID:
17822980
12.

Evolving paradigms in the medical treatment of glaucoma.

Cohen JS, Khatana AK, Greff LJ.

Int Ophthalmol. 2004 Oct-Dec;25(5-6):253-65. Epub 2006 Mar 7. Review.

PMID:
16532287
13.

[Normal pressure glaucoma: a diagnostic challenge].

Meier-Gibbons F, Stürmer J, Gloor B.

Klin Monbl Augenheilkd. 1995 Mar;206(3):157-60. German.

PMID:
7616723
14.

Normal-tension glaucoma: is it different from primary open-angle glaucoma?

Shields MB.

Curr Opin Ophthalmol. 2008 Mar;19(2):85-8. doi: 10.1097/ICU.0b013e3282f3919b. Review.

PMID:
18301279
15.

Glaucoma case report: a nutritional response.

Veach JE.

Optometry. 2003 Dec;74(12):775-81.

PMID:
14677729
16.

[Determination of individually endurable intraocular pressure (pressure of target) in primary glaucoma].

Shmyreva VF, Shmeleva-Demir OA, Mazurova IuV.

Vestn Oftalmol. 2003 Nov-Dec;119(6):3-5. Russian.

PMID:
14708161
17.

Pharmacological management of primary open-angle glaucoma: second-line options and beyond.

Webers CA, Beckers HJ, Nuijts RM, Schouten JS.

Drugs Aging. 2008;25(9):729-59. Review.

PMID:
18729546
18.

Disc hemorrhages and treatment in the early manifest glaucoma trial.

Bengtsson B, Leske MC, Yang Z, Heijl A; EMGT Group.

Ophthalmology. 2008 Nov;115(11):2044-8. doi: 10.1016/j.ophtha.2008.05.031. Epub 2008 Aug 9.

PMID:
18692244
19.

Factors that predict the benefit of lowering intraocular pressure in normal-tension glaucoma.

Cantor LB.

Am J Ophthalmol. 2003 Nov;136(5):920. No abstract available.

PMID:
14597048
20.

A 12-week study evaluating the efficacy of bimatoprost 0.03% in patients with pseudoexfoliative and open-angle glaucoma.

Ciancaglini M, Carpineto P, Agnifili L, Nubile M, Toto L, Mastropasqua L.

Eur J Ophthalmol. 2009 Jul-Aug;19(4):594-600.

PMID:
19551674
Items per page

Supplemental Content

Write to the Help Desk